載入...
Isoagglutinin Reduction in Human Immunoglobulin Products by Donor Screening
INTRODUCTION: Hemolysis is considered a class effect and a rare adverse event that can occur following therapy with human normal immunoglobulin for intravenous administration [i.e., intravenous immunoglobulin (IVIG)]. Anti-A/B isoagglutinins (also referred to as isohemagglutinins) originating from d...
Na minha lista:
| 發表在: | Biol Ther |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4254866/ https://ncbi.nlm.nih.gov/pubmed/24841428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-014-0016-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|